Home Tags China FDA Accepts JHL’s First Clinical Trial Application for clinical trials in Non-Hodgkin’s Lymphoma patients
Tag: China FDA Accepts JHL’s First Clinical Trial Application for clinical trials in Non-Hodgkin’s Lymphoma patients
China FDA Accepts JHL’s First Clinical Trial Application for clinical trials in Non-Hodgkin’s Lymphoma...
China FDA Accepts JHL's First Clinical Trial Application
WUHAN, China and HSINCHU, Taiwan, April 4, 2017 /PRNewswire/ -- JHL Biotech Inc. (Stock Code: 6540.TWO) is announcing that its Clinical Trial Application ("CTA") for use of JHL1101...